Notus Antitusivo Sabor Miel-Limón (Dextromethorphan Hydrobromide)

Dextromethorphan works by acting on the central nervous system. It blocks NMDA receptors and sigma‑1 receptors in the brainstem, which raises the threshold for coughing. This central action diminishes the cough reflex while preserving normal respiratory function.

The appropriate dose of Notus Antitusivo is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. Prescribers follow local guidelines and product labeling to set the exact regimen.

Safety data for dextromethorphan during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Notus Antitusivo contains dextromethorphan, a centrally acting antitussive, which differs from peripheral agents such as codeine that act on opioid receptors. Dextromethorphan generally has a lower risk of respiratory depression and does not produce opioid‑related dependence, making it a common first‑line choice for dry cough.

Store Notus Antitusivo at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and potency.

Notus Antitusivo is taken orally. The liquid is measured using the provided dosing device and swallowed. It should be taken as directed by a healthcare professional, typically with or without food, depending on the prescriber’s advice.

Serious risks, though rare, include allergic reactions such as rash or angioedema, serotonin syndrome when combined with serotonergic drugs, and respiratory depression at high doses. Patients should seek immediate medical attention if they experience severe dizziness, difficulty breathing, or signs of an allergic reaction.

Notus Antitusivo should be avoided by individuals taking monoamine oxidase inhibitors (MAOIs), those with known hypersensitivity to dextromethorphan, and patients with a history of severe psychiatric disorders that could be exacerbated by the drug. Children under the recommended age limit should also not receive this medication.